Medication info
Besilsartan Tablets 5/100 mg (Amlodipine, Losartan Potassium)

Besilsartan Tablets 5/100 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Huwons Co., Ltd.
Appearance
Pale pink oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502638 · Approved 2015.04.30 · Insurance code 670607240

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment target compared with monotherapy. This medicine is usually administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: Since an initial dose of losartan of 25 mg once daily is recommended for older adults aged 75 years or older, administration of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.

Ingredients

Manufacturer
Huwons Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is recommended for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of amlodipine or losartan. Additionally, it is used as initial therapy for patients with stage 2 hypertension who require combination therapy to reach target blood pressure. Therefore, it is effectively used for essential hypertension and blood pressure control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment target compared with monotherapy. This medicine is usually administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: Since an initial dose of losartan of 25 mg once daily is recommended for older adults aged 75 years or older, administration of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Due to its blood pressure-lowering effect, hypotensive symptoms may occur in patients with low intravascular blood volume upon initial use, so caution is needed. It should not be used in patients who are allergic to any of the ingredients or in those with severely impaired liver or heart function. In patients with high potassium levels in the blood or decreased kidney function, caution should be exercised, and regular testing is necessary. Dizziness or drowsiness may occur during treatment, so it is advisable to avoid driving or operating hazardous machinery. If taken with other antihypertensive medications, the blood pressure-lowering effect may be enhanced, so it should be taken according to the physician's instructions. This medication is not recommended for breastfeeding women, and caution is required for children and elderly patients aged 75 years or older as safety has not been adequately established. In case of overdose, blood pressure may drop too low or heart rhythm may become irregular, so dosage should be carefully followed.

Side effects

Dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, dyspepsia, nausea, gastroesophageal reflux, constipation, itching, hives, palpitations, flushing, orthostatic hypotension, facial flushing, shortness of breath, cough, conjunctival injection, increased urination, fatigue, edema, vasculitis, tension increase, sensory loss, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremor, erectile dysfunction, gynecomastia, changes in bowel habits, xerostomia, gastritis, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, hair loss, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, erythema, papular rash, nausea, heat sensation, impaired glucose tolerance, weakness, muscle cramps, low back pain, leg pain, congestion, upper respiratory tract infection, sinusitis, diarrhea, pharyngitis, myalgia, insomnia, edema, abdominal pain, angioedema, skin peeling, hemolysis, facial edema, fever, orthostatic effects, angina, second-degree AV block, cerebrovascular accident, hypotension, atrial fibrillation, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, loss of appetite, dental pain, flatulence, gastritis, anemia, gout, arm pain, hip pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle rigidity, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory reduction, loss of libido, memory impairment, migraine, hyperexcitability, panic disorder, sleep disorder, bronchitis, pharyngeal discomfort, epistaxis, rhinitis, respiratory congestion, dermatitis, dry skin, petechial hemorrhage, erythema, photosensitivity, rash, sweating, hives, blurred vision, burning sensation in the eyes, pain, conjunctivitis, dysgeusia, tinnitus, decreased vision, urethral infection, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactic syndrome, angioedema, vasculitis, anaphylactic reaction, intestinal angioedema, lethargy, thrombocytopenia, rhabdomyolysis, dysgeusia, dry cough, erythroderma, hyperkalemia, hyponatremia, elevated ALT, increased serum creatinine, elevated liver enzymes or serum bilirubin, hypotension, reflex tachycardia, systemic hypotension, shock, hypotension, tachycardia, bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it is best to store it at room temperature between 1 and 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

Pale pink oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.